Under the corporate slogan of “Peace of mind through diagnostic technology,” TAUNS has developed a variety of in vitro diagnostic test kits that apply our various diagnostic technologies and distributed them globally since its establishment in 1987.
The Covid-19 pandemic has had a major impact on people’s lives and on economies worldwide, and reinforced the importance of diagnostic technology.
Even though Covid-19 was reclassified as a Class 5 Infectious Disease in Japan on May 2023, we believe that the need for rapid diagnostic kits will continue to increase with future occurrences of simultaneous outbreaks of multiple infectious diseases including Covid-19.
TAUNS is focused on preparing for possible future occurrences of such social issues and will continue to work on stable supply, quality improvement and new product development. We will remain at the forefront of efforts to solve such dire social issues.
Going forward, we intend to contribute to society as a comprehensive diagnostics company that enriches lives and provides peace of mind by further strengthening and expanding our business in infectious diseases diagnostics and expanding into the fields of chronic diseases and pre- and post-disease testing.
Your continued understanding and support are greatly appreciated.
June, 2024
Masaki Nonaka
President and CEO
